Literature DB >> 33022334

Sestrin family - the stem controlling healthy ageing.

Alexander Haidurov1, Andrei V Budanov2.   

Abstract

Sestrins are a family of stress-responsive antioxidant proteins responsible for regulation of cell viability and metabolism. The best known Sestrin targets are mTORC1 and mTORC2 kinases that control different cellular processes including growth, viability, autophagy, and mitochondrial metabolism. Inactivation of the single Sestrin gene in invertebrates has an adverse impact on their healthspan and longevity, whereas each of the three Sestrin genes in mammals and other vertebrate organisms has a different impact on maintenance of a particular tissue, affecting its stress tolerance, function and regenerative capability. As a result, Sestrins attenuate ageing and suppress development of many age-related diseases including myocardial infarction, muscle atrophy, diabetes, and immune dysfunction, but exacerbate development of chronic obstructive pulmonary disease. Moreover, Sestrins play opposite roles in carcinogenesis in different tissues. Stem cells support tissue remodelling that influences ageing, and Sestrins might suppress ageing and age-related pathologies through control of stem cell biology. In this review, we will discuss the potential link between Sestrins, stem cells, and ageing.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell death; GATOR1/2; Mitochondria; Sestrin; mTORC1/2

Year:  2020        PMID: 33022334     DOI: 10.1016/j.mad.2020.111379

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  2 in total

1.  SESN2 prevents the slow-to-fast myofiber shift in denervated atrophy via AMPK/PGC-1α pathway.

Authors:  Xiaofan Yang; Pingping Xue; Zhenyu Liu; Wenqing Li; Chuyan Li; Zhenbing Chen
Journal:  Cell Mol Biol Lett       Date:  2022-08-09       Impact factor: 8.702

2.  Sestrin 2 levels are associated with emphysematous phenotype of COPD.

Authors:  Leonidas Angelakis; Andriana I Papaioannou; Evgenia Papathanasiou; Argiro Mazioti; Maria Kallieri; George Papatheodorou; George Patentalakis; Georgios Hillas; Spyridon Papiris; Nikolaos Koulouris; Stelios Loukides; Petros Bakakos
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.